Molecule Holdings Stock Shares Outstanding

EVRRF Stock  USD 0  0.00  0.00%   
Molecule Holdings fundamentals help investors to digest information that contributes to Molecule Holdings' financial success or failures. It also enables traders to predict the movement of Molecule Pink Sheet. The fundamental analysis module provides a way to measure Molecule Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molecule Holdings pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Molecule Holdings Company Shares Outstanding Analysis

Molecule Holdings' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Molecule Holdings Shares Outstanding

    
  97.78 M  
Most of Molecule Holdings' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molecule Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Molecule Holdings has 97.78 M of shares currently outstending. This is 45.84% lower than that of the Metals & Mining sector and significantly higher than that of the Materials industry. The shares outstanding for all United States stocks is 82.9% higher than that of the company.

Molecule Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecule Holdings' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Molecule Holdings could also be used in its relative valuation, which is a method of valuing Molecule Holdings by comparing valuation metrics of similar companies.
Molecule Holdings is currently under evaluation in shares outstanding category among its peers.

Molecule Fundamentals

About Molecule Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Molecule Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecule Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecule Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Molecule Pink Sheet

Molecule Holdings financial ratios help investors to determine whether Molecule Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecule with respect to the benefits of owning Molecule Holdings security.